Science-technology-innovation policies: Cuban experiences for development of biotechnology
Keywords:
Biotechnology, Medico-biological, Pharmaceutical, Science-technology-innovation, Policy, Link of universities, Biological plant, CubaAbstract
This paper deals with the relation between the development of biotechnology and science-technology innovation policies in Cuba as well as decision-making mechanisms. This shows the impacts from certain policies to development of biotechnology sector, especially in health care fields. The challenges Cuba has to face in biotechnology sector and science-technology-innovation policies as well as lessons from concrete cases may be found useful for Vietnam in process of making and implementing science-technology-innovation policies in present and future times.
Code: 20030201
Downloads
References
2. Castro, F. (1991). “Closing speech at the 7th Congress of the National Trade Union of Workers of Education, Science and Culture”. <http://www.cuba.cu/gobierno/discursos/1991/>
3. Cárdenas, Andrés (2009). “The Cuban Biotechnology Industry: Innovation and universal health care”; <https://pdfs.semanticscholar.org/df8b/95006fb835075a7b50a51cf3f61273b00304.pdf 01.06.2018>
4. Evenson, Debra (2007). “Cuba’s Biotechnology Revolution”. MEDICC Review, Fall 2007, Vol 9, No 1.
5. Grogg, P. (2001). Health Cuba: Nearly 80 Percent of Medicines Produced Locally, InterPress Service, March 19.
6. Herrera, L. (2008). “El camino hacia el éxito está lleno de fracasos. Interview given to Enrique Ubieta for La Calle del Medio”, Prensa Latina, Volume 5, November, Havana.
7. Kaplan, Warren and Richard Laing (2005), “Local Production of Pharmaceuticals: Industrial Policy and Access to Medicines”, Health, Nutrition, and Population Family, (HNP) Discussion Paper.
8. Lage, A. (2006). La economía del conocimiento y el socialismo: ¿hay una oportunidad para el desarrollo? <http://www.cubasocialista.cu/cs41/cseconomia.html.>
9. Limonta, M. (2002). Historia exitosa de una visión de futuro: la biotecnología médica en Cuba.
10. López, E., et. al, (2006). “Biotechnology in Cuba: 20 years of scientific, social and economic progress”, Journal of Commercial Biotechnology. Vol. 13. No 1. 1-11 octubre.
11. Majoli, M. (2002). Ciencia y Desarrollo en Cuba: aspectos del desarrollo científico y tecnológico cubano, FLACSO, Havana.
12. Núñez, J; Pérez, I (2007): “La construcción de capacidades de investigación e innovación en las universidades: el caso de la Universidad de La Habana”, Revista Educacion Superior y Sociedad: Universidad latinoamericana como centros de investigación y creación de conocimientos, Nueva Época, Año 1, Número 12, IESALC, Caracas, Agosto 2007, pp. 146-173.
13. Suárez, M. (2007). Interviews given to the authors.
14. Statista, (2018). “Biotechnology industry - Statistics and Facts” <https://www.statista.com/topics/1634/biotechnologyindustry/03/04/2018>
15. Tancer, R.S. (1995). “The Pharmaceutical Industry in Cuba”, Clinical Therapeutics, 17(4): 1-8.
16. Wright, R. (2016) Will Cuba Be The World's Next Leading Biotech Hub? Life science leader. October 17.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).